6640 Federal Register / Vol. 66, No. 14 / Monday, January 22, 2001 / Notices

Agenda: To get updates from the working

groups and to discuss the advocates section

of the April 2001 DCLG meeting.

Place: National Cancer Institute, 6116

Executive Boulevard, Suite 300 C, Rockville,

MD 20852, (Telephone Conference Call).

Contact Person: Elaine Lee, Acting

Executive Secretary, Office of Liaison

Activities, National Institute of Health,

National Cancer Institute, 6116 Executive

Boulevard, Suite 300 C, Bethesda, MD 20892,

301/594–3194.

This notice is being published less than 15

days prior to the meeting due to scheduling

conflicts.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: January 12, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–1633 Filed 1–19–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, Human

Factors in Breast Cancer Detection and

Diagnosis.

Date: February 8–10, 2001.

Time: 7:30 PM to 12 PM.

Agenda: To review and evaluate grant

applications.

Place: Wyndham Garden Brookfield, 18155

W. Bluemound Rd., Brookfield, WI 53045.

Contact Person: William D. Merritt,

Scientific Review Administrator, Grants

Review Branch, National Cancer Institute,

National Institutes of Health, 6116 Executive

Boulevard, Room 8034, MSC 8328, Bethesda,

MD 20892–8328, 301–496–9767.

This notice is being published less than 15

days prior to the meeting the due to the

timing limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: January 12, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–1634 Filed 1–19–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel,

Orientation and Review: Demonstration &

Education Research Grants.

Date: February 22, 2001.

Time: 1:15 PM to 4:45 PM.

Agenda: To review and evaluate grant

applications.

Place: Washington National Airport Hilton,

2399 Jefferson Davis Highway, Arlington, VA

22202.

Contact Person: Louise P. Corman,

Scientific Review Administrator, Review

Branch, Room 7180, Division of Extramural

Affairs, National Heart, Lung, and Blood

Institute, National Institutes of Health,

Bethesda, MD 20892.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: January 12, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–1635 Filed 1–19–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel,

Adhesion Molecules in Transfusion Biology.

Date: January 30, 2001.

Time: 11 AM to 5 PM.

Agenda: To review and evaluate grant

applications.

Place: Columbia Sheraton, 10207

Wincopin Circle, Columbia, MD 21044.

Contact Person: Jeffrey H. Hurst, Health

Scientist Administrator, 6701 Rockledge

Drive, Room 7208, Bethesda, MD 20892, 301–

435–0303.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: January 12, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–1636 Filed 1–19–01; 8:45 am]

BILLING CODE 4140–01–M